Clinical Trials Management System Market Size Report, 2023-2032
The global clinical trials management system market size was exhibited at USD 1.98 billion in 2022 and is projected to hit around USD 7.6 billion by 2032, growing at a CAGR of 14.4% during the forecast period 2023 to 2032.
Key Pointers:
Clinical Trials Management System Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 2.27 Billion |
| Market Size by 2032 | USD 7.6 Billion |
| Growth Rate From 2023 to 2032 | CAGR of 14.4% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Solution type, Delivery mode, Component, End-user |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled |
IQVIA Inc.; Medidata (Dassault Systèmes); Oracle; DATATRAK International, Inc.; Clario; SimpleTrials; Calyx; RealTime Software Solutions, LLC; Laboratory Corporation of America Holdings; Veeva Systems; Wipro Limited; PHARMASEAL International Ltd.
|
The rapid growth of healthcare IT, preference for decentralized clinical trials, initiatives by key companies, and an increasing number of clinical studies are anticipated to drive the growth of the market. According to the WHO, about 65,409 clinical trials were conducted in 2020 across the globe. This number was notably greater than the 60,543 trials conducted in 2019. This is estimated to boost demand for CTMS solutions.
The COVID-19 pandemic significantly impacted the Clinical Trials Management System (CTMS) market. This included disruption in clinical trials, hurdles in patient recruitment, and canceled or delayed studies. However, the negative impact was gradually reduced by several strategic measures taken by governments, regulatory bodies, and market stakeholders to ensure the continuity of R&D. The need to develop vaccines for the coronavirus also boosted the adoption of decentralized clinical trials. The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) released guidelines to urgently advance COVID-19 vaccine equity. The IFPMA reported that 5 of its members had received approval for COVID-19 vaccines while 14 more were under clinical development. Also, as per COVID-NMA (an initiative by WHO), over 750 studies were registered for COVID-19 vaccine development as of February 2022. This is expected to increase the adoption of CTM systems.
As per a study published in the U.S. National Library of Medicine in 2020, the pandemic resulted in delayed subject enrollment and operational gaps in most ongoing clinical trials. This in turn negatively impacted trial programs and data integrity. Globally, most sites conducting clinical trials other than COVID-19 were found to experience delays in timelines. In some cases, clinical trials were found to reach a complete halt of operations, thus impacting clinical research outcomes. In March 2020, the U.S. FDA published a guidance document on the Conduct of Clinical Trials of Medical Products during the pandemic. Similar guidelines supported the recovery of the clinical trial operations, and the number is anticipated to increase over time.
Rising government funding and investments by biotechnology and pharmaceutical firms are promoting medical research activities. This factor combined with technological advancements is anticipated to boost the market growth over the forecast period. For instance, cloud-based CTMS eliminates the expenses of hardware acquisition, installation, provisioning, maintenance, support, and software licensing. These systems automatically update software and patch management systems, which reduces the burden of in-house IT staff and saves costs. Furthermore, the cloud-based software enables access to the server through mobile with maximum data security.
The increasing number of decentralized clinical trials is anticipated to boost market growth in the coming years. These are also referred to as virtual, digital, mobile, siteless, and remote trials that often utilize telemedicine solutions. Labcorp's decentralized clinical trials (DCTs) solution for instance offers a suite of solutions to design and implement decentralized clinical trials, including the necessary infrastructure, technology, and services. Increasing product availability from key companies is also estimated to fuel market growth. Rave CTMS by Medidata, for instance, offers an intelligent automation and workflow management solution to efficiently manage and oversee clinical trials.
Clinical Trials Management System Market Segmentation
| By Solution Type | By Delivery Mode | By Component | By End-user |
|
|
|
|
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Nova one advisor’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information/Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Approach 1: Commodity Flow Analysis
1.6.1.1 Hybrid market estimation
1.6.1.2 CAGR Calculation
1.6.2 Approach 2: Parent Market Analysis
1.7 List Of Secondary Sources
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Clinical Trials Management System (Ctms) Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Analysis
3.1.1 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Rising Number Of Clinical Trials
3.2.1.2 Rising Number Of Virtual Or Decentralized Clinical Trials
3.2.1.3 Increasing Outsourcing Of Clinical Trial Studies
3.2.1.4 Increasing Demand For Eclinical Solutions
3.2.2 Market Restraint Analysis
3.2.2.1 Rising Data Privacy And Cybersecurity Concerns
3.2.2.2 Significant Costs Associated With Implementation
3.3 Industry Analysis - Porter's
3.3.1 Bargaining Power Of Suppliers
3.3.2 Bargaining Power Of Buyers
3.3.3 Threat Of Substitutes
3.3.4 Threat Of New Entrants
3.3.5 Competitive Rivalry
3.4 Pestel Analysis
3.4.1 Political & Legal Landscape
3.4.2 Economic Landscape
3.4.3 Environmental & Social Landscape
3.4.4 Technological Landscape
3.5 Covid-19 Impact Analysis
Chapter 4 Solution Type Estimates And Trend Analysis, 2020 - 2032
4.1 Solution Type Movement Analysis, 2020 - 2032
4.2 Clinical Trials Management System (Ctms) Market Share Analysis, 2022 & 2032
4.3 Enterprise
4.3.1 Enterprise Market Estimates And Forecasts, 2020 - 2032
4.4 Site
4.4.1 Site Market Estimates And Forecasts, 2020 - 2032
Chapter 5 Component Estimates And Trend Analysis, 2020 - 2032
5.1 Component Movement Analysis, 2020 - 2032
5.2 Clinical Trials Management System (Ctms) Market Share Analysis, 2022 & 2032
5.3 Software
5.3.1 Software Market Estimates And Forecasts, 2020 - 2032
5.4 Services
5.4.1 Services Market Estimates And Forecasts, 2020 - 2032
Chapter 6 Delivery Mode Estimates And Trend Analysis, 2020 - 2032
6.1 Delivery Mode Movement Analysis, 2020 - 2032
6.2 Clinical Trials Management System (Ctms) Market Share Analysis, 2022 & 2032
6.3 Web- & Cloud-Based
6.3.1 Web & Cloud-Based Market Estimates And Forecasts, 2020 - 2032
6.4 On-Premises
6.4.1 On-Premises Market Estimates And Forecasts, 2020 - 2032
Chapter 7 End-User Estimates & Trend Analysis, 2020 - 2032
7.1 End-User Movement Analysis, 2020 - 2032
7.2 Clinical Trials Management System (Ctms) Market Share Analysis, 2022 & 2032
7.3 Pharmaceutical & Biotechnology Firms
7.3.1 Pharmaceutical And Biotechnology Firms Market Estimates And Forecasts, 2020 - 2032
7.4 Medical Device Firms
7.4.1 Medical Device Firms Market Estimates And Forecasts, 2020 - 2032
7.5 Cros & Others
7.5.1 Cros & Others Market Estimates And Forecasts, 2020 - 2032
Chapter 8 Regional Estimates & Trend Analysis, 2020 - 2032
8.1 Regional Market Snapshot
8.2 Regional Market Share Analysis, 2022 & 2032
8.3 North America
8.3.1 North America Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.3.2 U.S.
8.3.2.1 U.S. Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.3.3 Canada
8.3.3.1 Canada Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4 Europe
8.4.1 Europe Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.2 Germany
8.4.2.1 Germany Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.3 Uk
8.4.3.1 Uk Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.4 France
8.4.4.1 France Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.5 Italy
8.4.5.1 Italy Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.6 Spain
8.4.6.1 Spain Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.7 Netherlands
8.4.7.1 Netherlands Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.8 Belgium
8.4.8.1 Belgium Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.4.9 Russia
8.4.9.1 Russia Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5 Asia Pacific
8.5.1 Asia Pacific Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.2 Japan
8.5.2.1 Japan Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.3 China
8.5.3.1 China Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.4 India
8.5.4.1 India Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.5 South Korea
8.5.5.1 South Korea Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.6 Australia
8.5.6.1 Australia Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.7 Thailand
8.5.7.1 Thailand Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.8 Singapore
8.5.8.1 Singapore Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.9 Malaysia
8.5.9.1 Malaysia Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.10 Indonesia
8.5.10.1 Indonesia Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.5.11 Philippines
8.5.11.1 Philippines Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.6 Latin America
8.6.1 Latin America Clinical Trial Management System Market Estimates And Forecasts, 2020 - 2032
8.6.2 Brazil
8.6.2.1 Brazil Clinical Trial Management System Market Estimates And Forecasts, 2020 - 2032
8.6.3 Mexico
8.6.3.1 Mexico Clinical Trial Management System Market Estimates And Forecasts, 2020 - 2032
8.6.4 Argentina
8.6.4.1 Argentina Clinical Trial Management System Market Estimates And Forecasts, 2020 - 2032
8.7 Middle East & Africa
8.7.1 Mea Clinical Trial Management System Market Estimates And Forecasts, 2020 - 2032
8.7.2 South Africa
8.7.2.1 South Africa Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.7.3 Saudi Arabia
8.7.3.1 Saudi Arabia Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
8.7.4 Uae
8.7.4.1 Uae Clinical Trial Management Systems Market Estimates And Forecasts, 2020 - 2032
Chapter 9 Competitive Landscape
9.1 Participant’s Overview
9.2 Financial Performance
9.3 Product/ Services Benchmarking
9.4 Participant Categorization
9.4.1 Strategy Mapping
9.4.1.1 Collaborations
9.4.1.2 Expansion
9.4.1.3 Mergers/Acquisitions
9.4.1.4 Partnerships
9.4.1.5 Product/Service Launch
9.5 Company Profile
9.5.1 IQVIA Inc.
9.5.2 Medidata (Dassault Systèmes)
9.5.3 Oracle
9.5.4 DATATRAK International, Inc.
9.5.5 Clario
9.5.6 SimpleTrials
9.5.7 Calyx
9.5.8 RealTime Software Solutions, LLC
9.5.9 Laboratory Corporation of America Holdings
9.5.10 Veeva Systems
9.5.11 Wipro Limited
9.5.12 PHARMASEAL International Ltd.
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers